Advancing Survivorship Support Through Virtual Health Equity Resources for Breast Cancer Responsive Education (HERCaRE)
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- Mayo Clinic
- 入组人数
- 200
- 试验地点
- 2
- 主要终点
- Survivorship engagement - login
研究概览
简要总结
This clinical trial studies how well a virtual support platform, the Health Equity Resources for Breast Cancer Responsive Education (HERCaRE) application (app), works in improving survivorship among Black survivors of breast cancer. The HERCaRE platform is a mobile-friendly app that includes culturally tailored educational materials, interactive content, and health equity resources to help patients better understand and manage survivorship after breast cancer treatment. This trial may help improve how digital health interventions can enhance survivorship support and access to resources.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults aged 18 and older
- •Self-identified Black women with a history of breast cancer
- •"Self-identified Black woman" refers to individuals who personally identify as a Black or African American woman, inclusive of cisgender women from diverse cultural backgrounds. This will be confirmed during a verbal eligibility screening conducted prior to enrollment
- •Completed active breast cancer treatment (e.g., surgery, chemotherapy, or radiation) at least one month prior to enrollment; survivors receiving long-term hormonal therapy are also eligible
- •Reside within the Mayo Clinic Florida catchment area
- •Have access to a smartphone or willingness to use alternative access points
- •"Alternative access points" refer to non-clinical settings through which participants may be made aware of the study, including support groups, community health events, churches, and partner organizations that engage with breast cancer survivors outside of the traditional healthcare setting
排除标准
- •Individuals without a history of breast cancer
- •Those unable to provide verbal consent
- •Individuals who lack the ability to engage with digital platforms, as determined during the screening process via brief questions assessing comfort and experience with mobile technology. Participants must be able to open the app, read content, and complete survey independently. iPads will be available for participants who do not have their own mobile device
研究组 & 干预措施
Supportive Care (HERCaRE app)
Patients use the HERCaRE app over 4-6 weeks on study.
干预措施: Discussion (Other)
Supportive Care (HERCaRE app)
Patients use the HERCaRE app over 4-6 weeks on study.
干预措施: Internet-Based Intervention (Other)
Supportive Care (HERCaRE app)
Patients use the HERCaRE app over 4-6 weeks on study.
干预措施: Interview (Other)
Supportive Care (HERCaRE app)
Patients use the HERCaRE app over 4-6 weeks on study.
干预措施: Survey Administration (Other)
结局指标
主要结局
Survivorship engagement - login
时间窗: Up to 6 weeks
Assessed by active use of the Health Equity Resources for Breast Cancer Responsive Education (HERCaRE) platform, defined as number of logins per participant.
Survivorship engagement - time
时间窗: Up to 6 weeks
Assessed by the length of time each participant spent using the HERCaRE platform.
Survivorship engagement - self-report
时间窗: Up to 6 weeks
Assessed by self-reported actions such as initiating conversations with providers or accessing survivorship resources. Information will be obtained through semi-structured interviews.
Adherence to follow-up care
时间窗: Up to 6 weeks
Assessed by participant self-reported scheduling or completion of appointments (e.g., mammograms, primary care physician visits). Information will be obtained through semi-structured interviews.
次要结局
- Participant satisfaction - HERCaRE Final Survey(Up to 6 weeks)
- Perceived usability - HERCaRE Final Survey(Up to 6 weeks)